Cardio-Oncology A-Z: CAR-T Cell Cardiotoxicity With Dr Daniel Chen

How common are cardiotoxic events in patients receiving CD19 CAR T cells? What are the risk factors?Подробнее

Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Management of Cardiac irAEsПодробнее

Cardio-Oncology A-Z: CMR in Cardio-oncology With Dr BaldassarreПодробнее

CAR-T Cell TherapyПодробнее

Northwestern Medicine Cardio-oncology ProgramПодробнее

Cardio-Oncology 2022 ( Part II ):Critical Management of Cardio-Vascular Toxicities in Cancer TherapyПодробнее

Cardio-Oncology: Understanding the Connections Between Heart Disease and CancerПодробнее

Medicine/Disease Series-Cardio-OncologyПодробнее

CAR T Cells: Beating Cancer with the Immune SystemПодробнее

Label-free Live Cell Imaging: Activated T-Cell Killing Cancer CellПодробнее

Augmenting T-Cell Immunity in Pancreatic CancerПодробнее

CAR T-Cell TherapyПодробнее

Dr. Andreadis Discusses Toxicities With CAR T-Cell TherapyПодробнее

Managing CRS and neurotoxicities associated with CAR-T in ZUMA-3Подробнее

Dr. Roboz on Challenges With CAR T-cell Therapy in ALLПодробнее

Regulatory and commercialization challenges with CAR T-cell therapyПодробнее

CAR T-Cell Therapy: How Does It Work?Подробнее